跳至主要内容
临床试验/JPRN-UMIN000020904
JPRN-UMIN000020904已完成3 期

1.2L polyethylene glycol + ascorbic acid versus 2.0L polyethylene glycol-electrolyte acid for outpatient bowel preparation. - 1.2L polyethylene glycol + ascorbic acid versus 2.0L polyethylene glycol-electrolyte acid for outpatient bowel preparation.

Takamatsu Red Cross Hospital0 个研究点目标入组 300 人开始时间: 2016年2月8日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who have known or suspected bowel obstruction or ileus. 2. Patients who have known or suspected perforation. 3. Patients who have significant gastroparesis or gastric outlet obstruction. 4. Patients with severe chronic renal failure (creatinine clearance <30 mL/minute) and severe congestive heart failure (New York Heart Association [NYHA] class III or IV). 5. Patients with sustained tachyarrhythmia. 6. Patients with uncontrolled hypertension (systolic blood pressure >170 mm Hg, diastolic blood pressure >100mmHg). 7. Patients with toxic colitis or megacolon. 8. Pregnant or lactating women.

研究者

相似试验

1.2L polyethylene glycol + ascorbic acid versus 2.0L... | 临床试验